[1]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
DOI=10.1093/nar/14.16.6773; PubMed=3755823 [NCBI, ExPASy, EBI, Israel, Japan]
Jaiswal A.K.,
Nebert D.W.,
Gonzalez F.J.;
"Human P3(450): cDNA and complete amino acid sequence.";
Nucleic Acids Res. 14:6773-6774(1986).
|
[2]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
PubMed=3462722 [NCBI, ExPASy, EBI, Israel, Japan]
Quattrochi L.C.,
Pendurthi U.R.,
Okino S.T.,
Potenza C.,
Tukey R.H.;
"Human cytochrome P-450 4 mRNA and gene: part of a multigene family that contains Alu sequences in its mRNA.";
Proc. Natl. Acad. Sci. U.S.A. 83:6731-6735(1986).
|
[3]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
PubMed=2575218 [NCBI, ExPASy, EBI, Israel, Japan]
Ikeya K.,
Jaiswal A.K.,
Owens R.A.,
Jones J.E.,
Nebert D.W.,
Kimura S.;
"Human CYP1A2: sequence, gene structure, comparison with the mouse and rat orthologous gene, and differences in liver 1A2 mRNA expression.";
Mol. Endocrinol. 3:1399-1408(1989).
|
[4]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
TISSUE=Liver;
PubMed=3681487 [NCBI, ExPASy, EBI, Israel, Japan]
Jaiswal A.K.,
Nebert D.W.,
McBride O.W.,
Gonzalez F.J.;
"Human P(3)450: cDNA and complete protein sequence, repetitive Alu sequences in the 3' nontranslated region, and localization of gene to chromosome 15.";
J. Exp. Pathol. 3:1-17(1987).
|
[5]
|
NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND VARIANT VAL-314.
TISSUE=Liver;
Zhuge J.,
Qian Y.,
Xie H.,
Yu Y.;
"Sequence of a new human cytochrome P450-1A2 cDNA.";
Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases.
|
[6]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
DOI=10.1097/00008571-200102000-00001; PubMed=11207026 [NCBI, ExPASy, EBI, Israel, Japan]
Corchero J.,
Pimprale S.,
Kimura S.,
Gonzalez F.J.;
"Organization of the CYP1A cluster on human chromosome 15: implications for gene regulation.";
Pharmacogenetics 11:1-6(2001).
|
[7]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ARG-73; ASN-104; PHE-111; VAL-205; TRP-281 AND ILE-438.
Livingston R.J.,
Rieder M.J.,
Shaffer T.,
Bertucci C.,
Baier C.N.,
Rajkumar N.,
Willa H.T.,
Daniels M.,
Downing T.K.,
Stanaway I.B.,
Nguyen C.P.,
Gildersleeve H.,
Cassidy C.M.,
Johnson E.J.,
Swanson J.E.,
McFarland I.,
Yool B.,
Park C.,
Nickerson D.A.;
"NIEHS-SNPs, environmental genome project, NIEHS ES15478, Department of Genome Sciences, Seattle, WA (URL: http://egp.gs.washington.edu).";
Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
|
[8]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan]
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
|
[9]
|
PROTEIN SEQUENCE OF 2-19.
PubMed=3517618 [NCBI, ExPASy, EBI, Israel, Japan]
Wrighton S.A.,
Campanile C.,
Thomas P.E.,
Maines S.L.,
Watkins P.B.,
Parker G.,
Mendez-Picon G.,
Haniu M.,
Shively J.E.,
Levin W.,
Guzelian P.S.;
"Identification of a human liver cytochrome P-450 homologous to the major isosafrole-inducible cytochrome P-450 in the rat.";
Mol. Pharmacol. 29:405-410(1986).
|
[10]
|
NUCLEOTIDE SEQUENCE [MRNA] OF 295-485.
TISSUE=Liver;
PubMed=3000715 [NCBI, ExPASy, EBI, Israel, Japan]
Quattrochi L.C.,
Okino S.T.,
Pendurthi U.R.,
Tukey R.H.;
"Cloning and isolation of human cytochrome P-450 cDNAs homologous to dioxin-inducible rabbit mRNAs encoding P-450 4 and P-450 6.";
DNA 4:395-400(1985).
|
[11]
|
VARIANT LEU-21.
PubMed=9884316 [NCBI, ExPASy, EBI, Israel, Japan]
Huang J.D.,
Guo W.C.,
Lai M.D.,
Guo Y.L.,
Lambert G.H.;
"Detection of a novel cytochrome P-450 1A2 polymorphism (F21L) in Chinese.";
Drug Metab. Dispos. 27:98-101(1999).
|
[12]
|
VARIANTS ASN-348; PHE-386; TYR-406 AND TRP-431.
DOI=10.1002/humu.48; PubMed=11295848 [NCBI, ExPASy, EBI, Israel, Japan]
Chevalier D.,
Cauffiez C.,
Allorge D.,
Lo-Guidice J.-M.,
Lhermitte M.,
Lafitte J.-J.,
Broly F.;
"Five novel natural allelic variants-951A->C, 1042G->A (D348N), 1156A->T (I386F), 1217G->A (C406Y) and 1291C->T (C431Y)-of the human CYP1A2 gene in a French Caucasian population.";
Hum. Mutat. 17:355-356(2001).
|
[13]
|
VARIANTS MET-83; GLN-168; LEU-186; CYS-212; SER-299 AND ILE-438.
DOI=10.1124/jpet.103.055798; PubMed=14563787 [NCBI, ExPASy, EBI, Israel, Japan]
Murayama N.,
Soyama A.,
Saito Y.,
Nakajima Y.,
Komamura K.,
Ueno K.,
Kamakura S.,
Kitakaze M.,
Kimura H.,
Goto Y.,
Saitoh O.,
Katoh M.,
Ohnuma T.,
Kawai M.,
Sugai K.,
Ohtsuki T.,
Suzuki C.,
Minami N.,
Ozawa S.,
Sawada J.;
"Six novel nonsynonymous CYP1A2 gene polymorphisms: catalytic activities of the naturally occurring variant enzymes.";
J. Pharmacol. Exp. Ther. 308:300-306(2004).
|
[14]
|
VARIANTS CYS-18; ARG-298; VAL-314 AND TRP-431.
DOI=10.1517/14622416.5.7.895; PubMed=15469410 [NCBI, ExPASy, EBI, Israel, Japan]
Solus J.F.,
Arietta B.J.,
Harris J.R.,
Sexton D.P.,
Steward J.Q.,
McMunn C.,
Ihrie P.,
Mehall J.M.,
Edwards T.L.,
Dawson E.P.;
"Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population.";
Pharmacogenomics 5:895-931(2004).
|
[15]
|
VARIANTS ARG-42; GLN-377 AND HIS-456.
DOI=10.2133/dmpk.20.24; PubMed=15770072 [NCBI, ExPASy, EBI, Israel, Japan]
Soyama A.,
Saito Y.,
Hanioka N.,
Maekawa K.,
Komamura K.,
Kamakura S.,
Kitakaze M.,
Tomoike H.,
Ueno K.,
Goto Y.,
Kimura H.,
Katoh M.,
Sugai K.,
Saitoh O.,
Kawai M.,
Ohnuma T.,
Ohtsuki T.,
Suzuki C.,
Minami N., ![]()
Kamatani N.,
Ozawa S.,
Sawada J.;
"Single nucleotide polymorphisms and haplotypes of CYP1A2 in a Japanese population.";
Drug Metab. Pharmacokinet. 20:24-33(2005).
|
[16]
|
VARIANT CYS-18.
DOI=10.1002/humu.20134; PubMed=15643613 [NCBI, ExPASy, EBI, Israel, Japan]
Jiang Z.,
Dalton T.P.,
Jin L.,
Wang B.,
Tsuneoka Y.,
Shertzer H.G.,
Deka R.,
Nebert D.W.;
"Toward the evaluation of function in genetic variability: characterizing human SNP frequencies and establishing BAC-transgenic mice carrying the human CYP1A1_CYP1A2 locus.";
Hum. Mutat. 25:196-206(2005).
|
[17]
|
EFFECT OF CAFFEINE METABOLISM ON RISKS OF MYOCARDIAL INFARCTION.
DOI=10.1001/jama.295.10.1135; PubMed=16522833 [NCBI, ExPASy, EBI, Israel, Japan]
Cornelis M.C.,
El-Sohemy A.,
Kabagambe E.K.,
Campos H.;
"Coffee, CYP1A2 genotype, and risk of myocardial infarction.";
JAMA 295:1135-1141(2006).
|
|
ExPASy Home page